youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
NUVB:NYSE
Nuvation Bio Inc
$4.76
arrow_downward
-0.10%(-0.0050) 1D
Oct 30, 3:00:10 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NUVB...
Open
$4.75
High
$4.80
Low
$4.60
Mkt. cap
1.67B
Avg. vol.
5.32M
Volume
5.06M
52-wk high
$9.75
52-wk low
$3.92
EPS
-$0.44
Beta
1.61
Shares outstanding
351.12M
No. of employees
305
Open
$4.75
High
$4.80
Low
$4.60
Mkt. cap
1.67B
Avg. vol.
5.32M
Volume
5.06M
52-wk high
$9.75
52-wk low
$3.92
EPS
-$0.44
Beta
1.61
Shares outstanding
351.12M
No. of employees
305
News stories
From web sources and news partners
bloomingbit
·
13 minutes ago
Morgan Stanley's Wilson Says US Stock Pullback Is Buying Opportunity, Sees S&P 500 Rising From 7,100 to 8,000
Benzinga
·
9 minutes ago
S&P 500 Is Up '19 For 19 Times' In Midterm November-April Window, According To Ryan Detrick
The Motley Fool
·
4 hours ago
The S&P 500's Shiller P/E Is Above 40. History Says What Happened the Only Other Time.
FourWeekMBA
·
9 hours ago
Apple Is Half the S&P 500’s Top Consumer Sales, Asymco Says
About Nuvation Bio Inc
CEODavid Hung
Employees305
Founded2018
Headquarters-
SectorPharmaceutical industry
Websitenuvationbio.com
Analyst ratings
Based on 10 analysts giving stock ratings to NUVB in the past 3 months
Strong buy
Buy
9
Hold
1
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for NUVB in the last 3 months.
Highest
Current $4.76
$21.00 (+341.18%)
Average
$13.63 (+186.34%)
Lowest
$7.00 (+47.06%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Unknown Analyst UBS | Hold | Maintained | $7.00 | +47.1% | 10/20/2026 |
Geoff Meacham Citi | Buy | Maintained | $12.00 | +152.1% | 10/15/2026 |
Leonid Timashev RBC Capital | Buy | Maintained | $20.00 | +320.2% | 10/12/2026 |
Priyanka Grover J.P. Morgan | Buy | Maintained | - | - | 09/15/2026 |
David Nierengarten Wedbush | Buy | Maintained | $11.00 | +131.1% | 09/15/2026 |
Gregory Renza Truist Financial | Buy | Maintained | - | - | 09/15/2026 |
Li Watsek Cantor Fitzgerald | Buy | Initiated | $12.00 | +152.1% | 08/21/2026 |
Mayank Mamtani B. Riley Securities | Buy | Maintained | $14.00 | +194.1% | 08/07/2026 |
Robert Burns H.C. Wainwright | Buy | Reiterated | $21.00 | +341.2% | 08/07/2026 |
Boris Peaker JonesTrading | Buy | Reiterated | $12.00 | +152.1% | 08/06/2026 |
Yaron Werber TD Cowen | Buy | Reiterated | - | - | 06/01/2026 |
Soumit Roy JonesTrading | Buy | Maintained | $12.00 | +152.1% | 04/06/2026 |
Michael Yee UBS | Hold | Maintained | $7.00 | +47.1% | 03/03/2026 |
Next call in 3 days
Wed, Nov 4, 11:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / -$0.10
Revenue / Est. (USD)
- / 34.42M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 13.12M | 41.86M | 83.23M | 31.69M |
Cost of goods sold | 3.35M | 1.28M | 5.99M | 9.47M |
Cost of revenue | 3.35M | 1.28M | 5.99M | 9.47M |
Research and development expenses | 28.85M | 34.30M | 35.05M | 30.66M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 37.36M | 40.33M | 38.31M | 42.59M |
Operating expense | 66.20M | 74.62M | 73.36M | 73.25M |
Total operating expenses | 69.55M | 75.90M | 79.35M | 82.72M |
Operating income | -56.43M | -34.04M | 3.88M | -51.04M |
Other non operating income | 1.14M | -1.18M | 3.11M | -179.00K |
EBT including unusual items | -55.79M | -36.59M | 5.40M | -62.84M |
EBT excluding unusual items | -55.80M | -36.59M | 5.39M | -53.38M |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -55.79M | -36.59M | 5.40M | -62.84M |
Net profit margin | -425.24% | -87.40% | 6.48% | -198.31% |
Earnings per share | -0.14 | -0.09 | 0.04 | -0.15 |
Interest and investment income | 6.03M | 5.30M | 5.11M | 4.60M |
Interest expense | -6.53M | -6.67M | -6.71M | -6.76M |
Net interest expenses | -501.00K | -1.38M | -1.60M | -2.16M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -55.90M | -33.50M | 4.42M | -50.50M |
Gain or loss from assets sale | -4.00K | 3.00K | - | -1.00K |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events